Abstract
The form of EBV/CMV co-infection gains rarely multi- pathogenicity and leads to viral myocarditis. Also, it may lead to progressive heart failure or sudden death. The aim of this study is to investigate the impact of low-dose colchicine therapy as adjunt to conventional heart failure therapy in the five patients with EBV/CMV co-infection leads to viral myocarditis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
